Biologics Safety Testing Market By Test Type (Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests, and Other Test Types), By Product (Services, Instruments and Reagents, and Kits), By Application (Tissue and Tissue-Related Products Testing, Cellular and Gene Therapy, Blood and Blood-Related Products Testing, Vaccine and Therapeutics Development, and Stem Cell Research)

Global biologics safety testing market registered USD 3,701.1 Million in 2022. The global industry is projected to register an incremental spend of about USD 6,830 Million during the forecast period with a Compounded Annual Growth Rate (CAGR) of 9.20% during 2022-2030.

A biologics product refers to the added product derivative from biological sources. They are used in animals and humans as medical devices. The rising demand for biologics to deal with a load of several chronic diseases is increasing the requirements for the biologics safety testing market. Also, the quick development in fresh product launches, the larger investment in life science and research & development, expansion in pharmaceutical and biopharmaceutical research, and growing incidence of chronic diseases are propelling the global market growth and will continue to grow over the forecast period.
Various key industrial players are highly investing in the advancement of biosimilar and biologic drugs production. It is found recently that the majority of the drug candidates in the discovery stage are biologics like peptides, proteins, and monoclonal antibodies where biologic drugs are projected to provide a large market share produced by the top pharmaceutical products during the forecast period.

Growth Factors

Furthermore, other factors like the increase in concerns in the cell culture contamination, augmentation in biosimilars and the biologics market, and the escalation in biopharmaceuticals research and development programs and investments. However, the ever-increasing biopharmaceutical outsourcing and promising markets are anticipated to for lucrative opportunities for the industrial players in the biologics safety testing market all over the globe.
Owing to the rising figure of COVID-19 patients, the vaccine production is projected to enhance the market of biologics safety testing having an essential quality assurance measure to make sure the patient safety. In addition, the rising implementation of endotoxin testing for drug development and COVID-19 research will be having a positive effect on market growth at a global level.

Regional Analysis

In terms of revenue, North America is contributing to the largest market growth across the world in the biologics safety testing market and will continue to grow in the future. This is due to the quick expansion in the biopharmaceutical production companies in the region. Also, other factors like the increasing awareness among consumers about product safety, rising demand for high-quality research tools for data reproducibility, Growing academic and government investments, and the presence of major market players are responsible for fueling the market of biologics safety testing in the North American region.

Top Market Players

The numerous initiatives by the market players and the use of biologics safety testing products and services in COVID-19 research widely have positively influenced the biologics safety testing market. This, in turn, is expected to grow the market revenue all over the world. Pace Analytical Services Inc., Merck KGaA, Charles River Laboratories, Cytovance Biologics Inc., Toxikon Corporation, Sartorius AG, WuXi Apptec, Thermo Fisher Scientific Inc., Lonza Group LTD, and SGS SA are key market players in the global biologics safety testing market.

Report Attribute Details
The market size value in 2022 USD 3,701.1 million
The revenue forecast in 2030 USD 6,830 million
Growth Rate CAGR of 9.20% from 2020 to 2028
The base year for estimation 2021
Historical data 2018 – 2020
Forecast period 2022 – 2030
Top Manufacturers Xilinx (US), United Microelectronics (Taiwan), Microchip Technology, Intel (US), Microchip (US), Lattice Semiconductor (US), Achronix (US), TSMC (Taiwan), QuickLogic (US), GLOBALFOUNDRIES (US), S2C Inc (US)
By Product Services, Instruments and Reagents, Kits
By Test Type Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests, Other Test Types
By Application
Tissue and Tissue-Related Products Testing, Cellular and Gene Therapy, Blood and Blood-Related Products Testing, Vaccine and Therapeutics Development, Stem Cell Research
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa

This report segments the global biologics safety testing market as follows:

Global Biologics Safety Testing Market: By Product

  • Services
  • Instruments and Reagents
  • Kits

Global Biologics Safety Testing Market: By Test Type

  • Bioburden Tests
  • Adventitious Agent Detection Tests
  • Residual Host Contamination Detection Tests
  • Cell Line Authentication and Characterization Tests
  • Sterility Tests
  • Endotoxin Tests
  • Other Test Types

Global Biologics Safety Testing Market: By Application

  • Tissue and Tissue-Related Products Testing
  • Cellular and Gene Therapy
  • Blood and Blood-Related Products Testing
  • Vaccine and Therapeutics Development
  • Stem Cell Research

Global Biologics Safety Testing Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

1. Preface
        1.1. Study Scope and Description
        1.2. Research Scope
        1.3. Research Methodology
                1.3.1. Market Research Process
                1.3.2. Market Research Methodology


2. Executive Summary
        2.1. Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)
        2.2. Biologics Safety Testing Market: Snapshot


3. Global Biologics Safety Testing Market– Industry Analysis
        3.1. Biologics Safety Testing Market: Market Growth Factors
        3.2. Market Drivers
                3.2.1. Growing concerns in the cell culture contamination
                3.2.2. Increased R&D and investment in biopharmaceuticals
        3.3. Market Restraints
                3.3.1. Restraint 1
                3.3.2. Restraint 2
        3.4. Market Opportunities
        3.5. Future Trends
        3.6. Porter’s Five Forces Analysis
        3.7. Market Attractiveness Analysis
                3.7.1. Market attractiveness analysis By Product
                3.7.2. Market attractiveness analysis By Test Type
                3.7.3. Market attractiveness analysis By Application
                3.7.4. Market attractiveness analysis By Region


4. Global Biologics Safety Testing Market– Competitive Landscape
        4.1. Company market share analysis
                4.1.1. Global Biologics Safety Testing Market: company market share, 2021
        4.2. Strategic development
                4.2.1. Mergers & Acquisitions
                4.2.2. Latest Product launches
                4.2.3. Partnerships, collaborations, agreements, and joint ventures
                4.2.4. Research & development and Regional expansion
        4.3. Value trend analysis


5. Global Biologics Safety Testing Market Synopsis – Product Analysis
        5.1. Global Biologics Safety Testing Market overview: By Product
                5.1.1. Global Biologics Safety Testing Market share, By Product, Revenue and Forecast 2022 and 2030
        5.2. Services
                5.2.1. Global Biologics Safety Testing Market by Services, Revenue and Forecast 2018–2030 (USD Million)
        5.3. Instruments and Reagents
                5.3.1. Global Biologics Safety Testing Market by Instruments and Reagents, Revenue and Forecast 2018–2030 (USD Million)
        5.4. Kits
                5.4.1. Global Biologics Safety Testing Market by Kits, Revenue and Forecast 2018–2030 (USD Million)


6. Global Biologics Safety Testing Market Synopsis – Test Type Analysis
        6.1. Global Biologics Safety Testing Market overview: By Test Type
                6.1.1. Global Biologics Safety Testing Market share, By Test Type, Revenue and Forecast 2022 and 2030
        6.2. Bioburden Tests
                6.2.1. Global Biologics Safety Testing Market by Bioburden Tests, Revenue and Forecast 2018–2030 (USD Million)
        6.3. Adventitious Agent Detection Tests
                6.3.1. Global Biologics Safety Testing Market by Adventitious Agent Detection Tests, Revenue and Forecast 2018–2030 (USD Million)
        6.4. Residual Host Contamination Detection Tests
                6.4.1. Global Biologics Safety Testing Market by Residual Host Contamination Detection Tests, Revenue and Forecast 2018–2030 (USD Million)
        6.5. Cell Line Authentication and Characterization Tests
                6.5.1. Global Biologics Safety Testing Market by Cell Line Authentication and Characterization Tests, Revenue and Forecast 2018–2030 (USD Million)
        6.6. Sterility Tests
                6.6.1. Global Biologics Safety Testing Market by Sterility Tests, Revenue and Forecast 2018–2030 (USD Million)
        6.7. Endotoxin Tests
                6.7.1. Global Biologics Safety Testing Market by Endotoxin Tests, Revenue and Forecast 2018–2030 (USD Million)
        6.8. Other Test Types
                6.8.1. Global Biologics Safety Testing Market by Other Test Types, Revenue and Forecast 2018–2030 (USD Million)


7. Global Biologics Safety Testing Market Synopsis – Application Analysis
        7.1. Global Biologics Safety Testing Market overview: By Application
                7.1.1. Global Biologics Safety Testing Market share, By Application, Revenue and Forecast 2022 and 2030
        7.2. Tissue and Tissue-Related Products Testing
                7.2.1. Global Biologics Safety Testing Market by Tissue and Tissue-Related Products Testing, Revenue and Forecast 2018–2030 (USD Million)
        7.3. Cellular and Gene Therapy
                7.3.1. Global Biologics Safety Testing Market by Cellular and Gene Therapy, Revenue and Forecast 2018–2030 (USD Million)
        7.4. Blood and Blood-Related Products Testing
                7.4.1. Global Biologics Safety Testing Market by Blood and Blood-Related Products Testing, Revenue and Forecast 2018–2030 (USD Million)
        7.5. Vaccine and Therapeutics Development
                7.5.1. Global Biologics Safety Testing Market by Vaccine and Therapeutics Development, Revenue and Forecast 2018–2030 (USD Million)
        7.6. Stem Cell Research
                7.6.1. Global Biologics Safety Testing Market by Stem Cell Research, Revenue and Forecast 2018–2030 (USD Million)


8. Global Biologics Safety Testing Market Synopsis - Regional Analysis
        8.1. Global Biologics Safety Testing Market overview: by Region
                8.1.1. Global Biologics Safety Testing Market share, by Region, Revenue and Forecast 2022 and 2030
        8.2. North America
                8.2.1. North America Biologics Safety Testing Market, Revenue and Forecast 2018-2030 (USD Million)
                8.2.2. North America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.2.3. North America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.2.4. North America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.2.5. The U.S.
                        8.2.5.1. The U.S. Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.2.5.2. The U.S. Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.2.5.3. The U.S. Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.2.6. Rest of North America
                        8.2.6.1. Rest of North America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.2.6.2. Rest of North America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.2.6.3. Rest of North America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
        8.3. Europe
                8.3.1. Europe Biologics Safety Testing Market, Revenue and Forecast 2018-2030 (USD Million)
                8.3.2. Europe Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.3.3. Europe Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.3.4. Europe Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.3.5. UK
                        8.3.5.1. U.K. Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.5.2. U.K. Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.5.3. U.K. Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.3.6. France
                        8.3.6.1. France Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.6.2. France Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.6.3. France Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.3.7. Germany
                        8.3.7.1. Germany Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.7.2. Germany Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.7.3. Germany Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.3.8. Rest of Europe
                        8.3.8.1. Rest of Europe Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.8.2. Rest of Europe Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.3.8.3. Rest of Europe Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
        8.4. Asia Pacific
                8.4.1. Asia Pacific Biologics Safety Testing Market, Revenue and Forecast 2018-2030 (USD Million)
                8.4.2. Asia Pacific Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.4.3. Asia Pacific Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.4.4. Asia Pacific Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.4.5. China
                        8.4.5.1. China Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.5.2. China Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.5.3. China Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.4.6. Japan
                        8.4.6.1. Japan Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.6.2. Japan Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.6.3. Japan Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.4.7. India
                        8.4.7.1. India Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.7.2. India Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.7.3. India Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.4.8. Rest of Asia Pacific
                        8.4.8.1. Rest of Asia Pacific Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.8.2. Rest of Asia Pacific Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.4.8.3. Rest of Asia Pacific Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
        8.5. Latin America
                8.5.1. Latin America Biologics Safety Testing Market, Revenue and Forecast 2018-2030 (USD Million)
                8.5.2. Latin America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.5.3. Latin America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.5.4. Latin America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.5.5. Brazil
                        8.5.5.1. Brazil Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.5.5.2. Brazil Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.5.5.3. Brazil Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.5.6. Rest of Latin America
                        8.5.6.1. Rest of Latin America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                        8.5.6.2. Rest of Latin America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                        8.5.6.3. Rest of Latin America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
        8.6. The Middle East and Africa
                8.6.1. The Middle East and Africa Biologics Safety Testing Market, Revenue and Forecast 2018-2030 (USD Million)
                8.6.2. The Middle East and Africa Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.6.3. The Middle East and Africa Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.6.4. The Middle East and Africa Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.6.5. Saudi Arabia Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.6.6. Saudi Arabia Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.6.7. Saudi Arabia Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.6.8. UAE Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.6.9. UAE Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.6.10. UAE Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)
                8.6.11. The Rest of Middle East and Africa Biologics Safety Testing Market, By Product, Revenue and Forecast 2018-2030 (USD Million)
                8.6.12. The Rest of Middle East and Africa Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018-2030 (USD Million)
                8.6.13. The Rest of Middle East and Africa Biologics Safety Testing Market, By Application, Revenue and Forecast 2018-2030 (USD Million)


9. Company Profiles
        9.1. Pace Analytical Services Inc.
                9.1.1. Overview
                9.1.2. Financials Synopsis
                9.1.3. Product Portfolio
                9.1.4. Business Tactic
                9.1.5. Key Developments
        9.2. Merck KGaA
                9.2.1. Overview
                9.2.2. Financials Synopsis
                9.2.3. Product Portfolio
                9.2.4. Business Tactic
                9.2.5. Key Developments
        9.3. Charles River Laboratories
                9.3.1. Overview
                9.3.2. Financials Synopsis
                9.3.3. Product Portfolio
                9.3.4. Business Tactic
                9.3.5. Key Developments
        9.4. Cytovance Biologics Inc.
                9.4.1. Overview
                9.4.2. Financials Synopsis
                9.4.3. Product Portfolio
                9.4.4. Business Tactic
                9.4.5. Key Developments
        9.5. Toxikon Corporation
                9.5.1. Overview
                9.5.2. Financials Synopsis
                9.5.3. Product Portfolio
                9.5.4. Business Tactic
                9.5.5. Key Developments
        9.6. Sartorius AG
                9.6.1. Overview
                9.6.2. Financials Synopsis
                9.6.3. Product Portfolio
                9.6.4. Business Tactic
                9.6.5. Key Developments
        9.7. WuXiApptec
                9.7.1. Overview
                9.7.2. Financials Synopsis
                9.7.3. Product Portfolio
                9.7.4. Business Tactic
                9.7.5. Key Developments
        9.8. Thermo Fisher Scientific Inc.
                9.8.1. Overview
                9.8.2. Financials Synopsis
                9.8.3. Product Portfolio
                9.8.4. Business Tactic
                9.8.5. Key Developments
        9.9. Lonza Group LTD
                9.9.1. Overview
                9.9.2. Financials Synopsis
                9.9.3. Product Portfolio
                9.9.4. Business Tactic
                9.9.5. Key Developments
        9.10. SGS SA
                9.10.1. Overview
                9.10.2. Financials Synopsis
                9.10.3. Product Portfolio
                9.10.4. Business Tactic
                9.10.5. Key Developments


10. Appendix

List of Figures

1. Market Research Overview
2. Market Research Methodology
3. Global Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Biologics Safety Testing Market Attractiveness, By Product
6. Global Biologics Safety Testing Market Attractiveness, By Test Type
7. Global Biologics Safety Testing Market Attractiveness, By Application
8. Global Biologics Safety Testing Market share by Product, Revenue and Forecast 2022 and 2030 (USD Million)
9. Global Biologics Safety Testing Market by Services, Revenue and Forecast 2018–2030 (USD Million)
10. Global Biologics Safety Testing Market by Instruments and Reagents, Revenue and Forecast 2018–2030 (USD Million)
11. Global Biologics Safety Testing Market by Kits, Revenue and Forecast 2018–2030 (USD Million)
12. Global Biologics Safety Testing Market share by Test Type, Revenue and Forecast 2022 and 2030 (USD Million)
13. Global Biologics Safety Testing Market by Bioburden Tests, Revenue and Forecast 2018–2030 (USD Million)
14. Global Biologics Safety Testing Market by Adventitious Agent Detection Tests, Revenue and Forecast 2018–2030 (USD Million)
15. Global Biologics Safety Testing Market by Residual Host Contamination Detection Tests, Revenue and Forecast 2018–2030 (USD Million)
16. Global Biologics Safety Testing Market by Cell Line Authentication and Characterization Tests, Revenue and Forecast 2018–2030 (USD Million)
17. Global Biologics Safety Testing Market by Sterility Tests, Revenue and Forecast 2018–2030 (USD Million)
18. Global Biologics Safety Testing Market by Endotoxin Tests, Revenue and Forecast 2018–2030 (USD Million)
19. Global Biologics Safety Testing Market by Other Test Types, Revenue and Forecast 2018–2030 (USD Million)
20. Global Biologics Safety Testing Market share by Application, Revenue and Forecast 2022 and 2030 (USD Million)
21. Global Biologics Safety Testing Market by Tissue and Tissue-Related Products Testing, Revenue and Forecast 2018–2030 (USD Million)
22. Global Biologics Safety Testing Market by Cellular and Gene Therapy, Revenue and Forecast 2018–2030 (USD Million)
23. Global Biologics Safety Testing Market by Blood and Blood-Related Products Testing, Revenue and Forecast 2018–2030 (USD Million)
24. Global Biologics Safety Testing Market by Vaccine and Therapeutics Development, Revenue and Forecast 2018–2030 (USD Million)
25. Global Biologics Safety Testing Market by Stem Cell Research, Revenue and Forecast 2018–2030 (USD Million)
26. Global Biologics Safety Testing Market share, by Region, Revenue and Forecast 2022 and 2030
27. North America Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)
28. Europe Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)
29. Asia Pacific Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)
30. Latin America Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)
31. The Middle East and Africa Biologics Safety Testing Market, Revenue and Forecast 2018–2030 (USD Million)

List of Tables

1. Global Biologics Safety Testing Market: snapshot
2. Drivers of the Biologics Safety Testing Market: impact analysis
3. North America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
4. North America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
5. North America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
6. The U.S. Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
7. The U.S. Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
8. The U.S. Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
9. Rest of North America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
10. Rest of North America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
11. Rest of North America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
12. Europe Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
13. Europe Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
14. Europe Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
15. UK Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
16. UK Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
17. UK Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
18. France Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
19. France Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
20. France Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
21. Germany Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
22. Germany Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
23. Germany Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
24. Rest of Europe Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
25. Rest of Europe Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
26. Rest of Europe Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
27. Asia Pacific Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
28. Asia Pacific Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
29. Asia Pacific Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
30. China Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
31. China Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
32. China Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
33. Japan Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
34. Japan Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
35. Japan Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
36. India Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
37. India Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
38. India Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
39. Rest of Asia Pacific Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
40. Rest of Asia Pacific Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
41. Rest of Asia Pacific Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
42. Latin America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
43. Latin America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
44. Latin America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
45. Brazil Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
46. Brazil Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
47. Brazil Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
48. Rest of Latin America Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
49. Rest of Latin America Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
50. Rest of Latin America Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
51. The Middle East and Africa Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
52. The Middle East and Africa Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
53. The Middle East and Africa Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
54. Saudi Arabia Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
55. Saudi Arabia Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
56. Saudi Arabia Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
57. South Africa Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
58. South Africa Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
59. South Africa Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)
60. Rest of the Middle East & Africa Biologics Safety Testing Market, By Product, Revenue and Forecast 2018–2030 (USD Million)
61. Rest of the Middle East & Africa Biologics Safety Testing Market, By Test Type, Revenue and Forecast 2018–2030 (USD Million)
62. Rest of the Middle East & Africa Biologics Safety Testing Market, By Application, Revenue and Forecast 2018–2030 (USD Million)

Research Framework

Vertex Market Research presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources
  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers
Secondary sources
  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis
  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights
Data Validation
  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative
  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis
Quantitative
  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Frequently Asked Questions About This Report

Xilinx (US), United Microelectronics (Taiwan), Microchip Technology, Intel (US), Microchip (US), Lattice Semiconductor (US), Achronix (US), TSMC (Taiwan), QuickLogic (US), GLOBALFOUNDRIES (US), S2C Inc (US)

In 2022, North America has the most share.

These factors, as well as concerns over cell culture contamination and increased biopharmaceutical R&D activities, are driving the growth of the global biologics safety testing market. In addition, emerging markets and increasing outsourcing of biopharmaceutical services are expected to provide significant growth opportunities for market participants in the biologics safety testing market.

Biologics safety testing market players and COVID-19 researchers have taken a variety of steps to improve their understanding of the Coronavirus, which has resulted in more accurate results. Thus, COVID-19 has had an impact on the biologics safety testing market to some extent because vaccine manufacturing is expected to increase as a result of COVID-19, and bacterial safety testing will be an important quality assurance measure to ensure patient safety.

Up